<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03027219</url>
  </required_header>
  <id_info>
    <org_study_id>S2016-2043-0003</org_study_id>
    <nct_id>NCT03027219</nct_id>
  </id_info>
  <brief_title>Blood Flow Change After Free Flap Surgery in Diabetic Patients</brief_title>
  <official_title>Prospective Observational Study of the Changes of Blood Flow of Arterial Anastomosis-site of Free Flap in Diabetic Patients Who Undergoing Free Flap Transfer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Asan Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Asan Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      We aim to evaluate the flow change of arterial anastomosis site during free flap surgery in
      diabetic patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objective: flow change of arterial anastomosis site during free flap surgery in diabetic
      patients.

      Background: No research was published about flow change of arterial anastomosis site of the
      free flap during surgery.

      Plan: Using Duplex sonography, various parameters related flap perfusion will be evaluated
      before and after the administration of alprostadil.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 31, 2017</start_date>
  <completion_date type="Anticipated">January 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Flow change</measure>
    <time_frame>before alprostadil administration, 30 mins after alprostadil administration</time_frame>
    <description>Peak velocity of anastomosis-site of free flap</description>
  </primary_outcome>
  <enrollment type="Anticipated">44</enrollment>
  <condition>Diabetes</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Alprostadil</intervention_name>
    <description>Vasodilator for anastomosis-site of free flap</description>
    <other_name>Eglandin</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Diabetic patients who are undergoing free flap surgery
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Plan to receive free flap transfer under general anesthesia

          2. Age: &gt;=18 and &lt;80 years old

          3. History of diabetes mellitus

          4. Administration of alprostadil during surgery

          5. Volunteer, who are provided written informed consent prior to study participation

        Exclusion Criteria:

          1. Refuse the participation of study

          2. &gt;= American society of anesthesiologist physical status IV

          3. Use of any vasopressor or inotropic for hemodynamic instability before participation
             of study

          4. Inappropriate subjects who are identified by researchers
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Young-kug Kim, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Asan Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Seok-joon Jin, MD, PhD</last_name>
    <phone>82-2-3010-0808</phone>
    <email>cerebellum@amc.seoul.kr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Young-kug Kim, MD, PhD</last_name>
    <phone>82-2-3010-5976</phone>
    <email>kyk@mac.seoul.kr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Asan Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>05505</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seok-joon Jin, Dr.</last_name>
      <phone>82-2-3010-0808</phone>
      <email>cerebellum@amc.seoul.kr</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 18, 2017</study_first_submitted>
  <study_first_submitted_qc>January 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 23, 2017</study_first_posted>
  <last_update_submitted>April 5, 2018</last_update_submitted>
  <last_update_submitted_qc>April 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Asan Medical Center</investigator_affiliation>
    <investigator_full_name>Young-Kug Kim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alprostadil</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

